HOX Therapeutics

Hox is a preclinical-stage biotechnology company focused on the discovery and development of targeted medicines for the treatment of cancer. The company works on designing therapies that target cancer cells.
  • Cancer therapies
  • Novel targeted medicines
Size
Small
Phone
N/A
Website
hoxtherapeutics.com
Email
N/A
Locations
Unit 24, surrey technology centre, 40 Occam Rd, GU2 7YG
07785714276
Digital Popularity
Social Media
Competitors
SiSaf Ltd
SiSaf is a biopharmaceutical company developing RNA therapeutics that are principally focused on rare genetic disorders.
Company Details
HOX Therapeutics is operated by Hox Therapeutics Limited and is a Active company incorporated on 22 February 2013 with the registered office located in Thame, Oxfordshire. Hox Therapeutics Limited was registered 12 years ago.
Status
Active
Size
Micro
Directors
6
Age
12 years old
Employees
6
Turnover
Unreported
Total Assets
£1.09M
Cash in Bank
£785.78K
Total Liabilities
-£158.28K
Anthony James Culverwell
Director • British • Lives in England • Born in Aug 1956
Dr Colin John Story
Director • British • Lives in UK • Born in Jan 1971
Mr Randeep Singh Grewal
Director • British • Lives in England • Born in Jan 1967
Dr Fiona McLaughlin
Director • Chief Scientific Officer • British • Lives in England • Born in Nov 1969
Prof Hardev Singh Pandha
Director • Consultant Medical Oncologist • British • Lives in UK • Born in Sep 1962
Mr Nicholas Charles Adams
Director • Chief Executive Officer • British • Lives in England • Born in May 1964
More information on Hox Therapeutics Limited
Teams
All
2
Management
1
Accounting
1
Nicholas Adams
Chief Executive Officer • Joined Jun 2023
Catherine Keegan
Financial Controller • Joined Jan 2019
Nicholas Adams
Chief Executive Officer • Joined Jun 2023
Catherine Keegan
Financial Controller • Joined Jan 2019